Pharma Surge
Pharma Surge
Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

01

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Open hub

Trials

02

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Open hub

Pipeline

03

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Open hub
Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

8,238 stories indexed, page 30 of 138

🇺🇸Researchnejm.org
Featured signal

NEJM Outbreaks Update — Andes Hantavirus

Publisher

NEJM

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

NEJMOriginal publisher link

Canonical metadata stays public, while full text remains on the original site.

🇮🇹Researchhumanitas-research.com

Maternal interferon and brain development: new clues about neurodevelopment disorders

Humanitas Research Hospital (Milan)Original source
🌍Researchfiercepharma.com

GLP-1 manufacturer CordenPharma strikes deal for peptide CDMO, lining up new production sites in US and China

Fierce Pharma ManufacturingOriginal source
🌍Industryapple.com

After the Whistle with Brendan Hunt and Rebecca Lowe returns

Apple Health NewsroomOriginal source
🇬🇧Researchmed.cam.ac.uk

John McCafferty: The antibody pioneer

University of Cambridge - Clinical Medicine NewsOriginal source
🇩🇪Mediacharite.de

Lebensretter auf vier Rädern: Das ECMObil der Charité

Charité - Universitätsmedizin Berlin (EN)Original source
🇩🇪Researchklinikum.uni-heidelberg.de

Antimetaboliten im Fokus: Neue Emmy-Noether-Nachwuchsgruppe erforscht Wirkmechanismen bestimmter Krebsmedikamente

Universitätsklinikum HeidelbergOriginal source
🇺🇸Mediabio-itworld.com

Bio-IT World VIP Conference: Exploring Breadth vs. Depth

Bio-IT WorldOriginal source
🇨🇭Industryroche.com

Roche launches the Liver Disease Panel, the first suite of certified algorithms to support Chronic Liver Disease management

Roche NewsroomOriginal source
🇦🇺Researchnews.flinders.edu.au

Flinders University joins the 2050 Alliance

Flinders University - Health & MedOriginal source
🇯🇵Regulatorypmda.go.jp

[YAKKYOKUKATA]Schedule of JP19-I Publication posted

PMDA JapanOriginal source
🌍Industrycibeles.com.uy

STIGMAR XTRA

Cibeles (Uruguay)Original source
🌍Industrycibeles.com.uy

Stigmar xtra

Cibeles (Uruguay)Original source
🇺🇸Researchonlinejcf.com

Remote Working Post-COVID-19: A New Risk Factor for Heart Failure in the Young? Trends in Heart Failure Hospitalisations in Ireland from 2017 to 2023

Journal of Cardiac FailureOriginal source
🇺🇸Researchnewsroom.clevelandclinic.org

Cleveland Clinic Analysis Finds Bempedoic Acid Reduces Risk of Serious Blood Clots in Statin-Intolerant Patients

Cleveland Clinic Main CampusOriginal source
🇺🇸Researchnews.emory.edu

Angela Dash to join Emory University Ombuds Office | Emory University | Atlanta GA

Emory University School of MedicineOriginal source
🇺🇸Industryir.unither.com

United Therapeutics Corporation to Present at the Jefferies Global Healthcare Conference

United TherapeuticsOriginal source
🌍Mediashoulderinnovations.com

Shoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Shoulder Innovations (ProVoyance + Micro-Robotic)Original source
🌍Industrydarebioscience.com

Press Release: Daré Bioscience Receives NIH Funding Award Notice to Advance DARE-HPV, its Novel Investigational Treatment for Persistent High-Risk HPV Infection, the Most Common Cause of Cervical Cancer

Dare BioscienceOriginal source
🇺🇸Industrytechcyte.com

Labopat diagnostics® goes live with Techcyte Fusion®, expanding access to digital pathology across Mexico

TechcyteOriginal source
🇺🇸Researchorbimed.com

Lilly announces three acquisitions to build infectious disease portfolio

OrbiMedOriginal source
🇺🇸Industryyprime.com

OCT UK & Ireland 2026

YPrimeOriginal source
🇺🇸CROmedpace.com

Q&A with Medpace’s Two New Neurology Experts

MedpaceOriginal source
🌍Industryir.allogene.com

May 26, 2026 3:30 PM EDT : TD Cowen 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA

Allogene TherapeuticsOriginal source
🌍Industryir.allogene.com

June 3, 2026 8:10 AM EDT : Jefferies Global Healthcare Conference, New York

Allogene TherapeuticsOriginal source
🌍Industryir.allogene.com

June 9, 2026 : H.C. Wainwright 4th Annual Cell Therapy Virtual Conference

Allogene TherapeuticsOriginal source
🇺🇸CROcaidya.com

Pharmacovigilance and Safety Reporting Requirements for Clinical Trials

Caidya (Clinipace)Original source
🇫🇷Regulatoryleem.org

Thérapies ciblées et anticorps : une vague d’innovations sans précédent arrive sur le marché… l’Europe saura-t-elle en faire bénéficier les patients ?

LEEM FranceOriginal source
🇨🇭Industryinterpharma.ch

3 Fragen an unser neues Boardmitglied: Jérome Garcin, General Manager for Switzerland and Austria bei Bristol Myers Squibb

Interpharma SwitzerlandOriginal source
🌍Mediasaama.com

Why Startup Delays Often Begin with Electronic Data Capture Design

SaamaOriginal source
🌍Industryir.allogene.com

Allogene Therapeutics Announces Participation in Upcoming Investor Conferences

Allogene TherapeuticsOriginal source
🇺🇸Industryinvestors.abeonatherapeutics.com

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences

Abeona TherapeuticsOriginal source
🇬🇧Industrygsk.com

GSK to showcase long-term outcomes and pipeline expansion with latest oncology research at ASCO and EHA

GSK NewsOriginal source
🇫🇷Researchchru-strasbourg.fr

Journée mondiale de la recherche : Une maison de la recherche au cœur de l’activité des HUS

Hôpitaux Universitaires de StrasbourgOriginal source
🌍Industrynervgen.com

NervGen Announces Positive Independent, Blinded Biomechanical Gait Analyses Demonstrating Genuine Neural Recovery with NVG-291 in Phase 1b/2a CONNECT SCI Study

NervGen PharmaOriginal source
🇺🇸Devicesir.idexx.com

IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

IDEXX LaboratoriesOriginal source
🇩🇪Researchuni-heidelberg.de

Prestigious Award for Heidelberg Pain Researcher

Heidelberg UniversityOriginal source
🌍Mediaevaluate.com

ADCs remain in dealmakers’ sights. Here’s why

Evaluate VantageOriginal source
🌍Mediaevaluate.com

Meet the Team: Paul Verdin

Evaluate VantageOriginal source
🇩🇪Researchklinikum.uni-heidelberg.de

Entwicklung aus Heidelberg revolutioniert Hepatitis D-Therapie weltweit: US-Arzneimittelbehörde FDA lässt Hepatitis-Medikament Hepcludex (Bulevirtide) zu

Universitätsklinikum HeidelbergOriginal source
🌍Researchfiercepharma.com

SK bioscience links up with Colombia to enable local production of varicella vaccine

Fierce Pharma ManufacturingOriginal source
🇧🇪Regulatoryfamhp.be

Jyseleca®

FAMHP BelgiumOriginal source
🇫🇷Researchchru-strasbourg.fr

Des soignant et des patients des HUS mobilisés pour sensibiliser au don d’organes

Hôpitaux Universitaires de StrasbourgOriginal source
🌍Medianovartis.com

Pushing the prostate cancer treatment frontier: Radioligand therapy and beyond

NovartisOriginal source
🇫🇷Researchchru-strasbourg.fr

SANTEXPO 2026 : Récompensés et présents, les HUS ont porté leurs ambitions

Hôpitaux Universitaires de StrasbourgOriginal source
🇫🇷Industryipsen.com

“I Really Witnessed It First Hand”: How Personal Experience Shapes Loubna Ouriaghli’s Work

Ipsen RSSOriginal source
🇨🇭CDMOsiegfried.ch

Siegfried successfully places senior bonds of CHF 200 million

SiegfriedOriginal source
🇯🇵Industrynewsroom.astellas.com

Astellas Announces Five-Year Corporate Strategic Plan to Deliver Greater VALUE Faster for Patients and Position Itself as a Sustainable Growth Company

Astellas PharmaOriginal source
🇫🇷Researchinserm.fr

Pourra-t-on hiberner un jour ?

InsermOriginal source
🌍Medianovartis.com

New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength

NovartisOriginal source
🇺🇸Mediabio-itworld.com

Follow the Money: AI Drug Design Engine, Treating Multiple Myeloma, Quantum Healthcare Platform

Bio-IT WorldOriginal source
🇦🇺Researchnews.flinders.edu.au

Autistic Australians three times more likely to be homeless

Flinders University - Health & MedOriginal source
🇯🇵Regulatorypmda.go.jp

[SHINSA]English Translation of Review Report: Elevidys and Vyjuvek Gel

PMDA JapanOriginal source
🇯🇵Industrychugai-pharm.co.jp

中外製薬、令和8年度全国発明表彰最高位の「恩賜発明賞」を受賞 ～リサイクリング抗体技術が、医薬品研究への貢献として評価～

Chugai Pharmaceutical NewsOriginal source
🇯🇵Industrychugai-pharm.co.jp

Chugai Receives “The Imperial Invention Prize,” the Highest Honor of the FY2026 National Commendation for Invention — Recycling Antibody Technology Recognized for its Contribution to Pharmaceutical Research —

Chugai PharmaceuticalOriginal source
🌍Regulatorypharmac.govt.nz

Pharmac extending consultation period on the proposed changes to diabetes medicine criteria

Pharmac New ZealandOriginal source
🌍Regulatorypharmac.govt.nz

Agenda for August 2026 Cancer Treatments advisory committee (CTAC) meeting

Pharmac New ZealandOriginal source
🌍Regulatorypharmac.govt.nz

Agenda for June 2026 Cancer Treatments advisory committee (CTAC) meeting

Pharmac New ZealandOriginal source
🇺🇸Industrythefdalawblog.com

Old Drugs, New Tricks: FDA’s Drug Repurposing Initiative

Hyman, Phelps & McNamara (FDA Law)Original source
🇬🇧Researchnature.com

DOCTER: a genetically encoded switchable protein module for ERα-mediated transcriptional regulation

Nature Gene TherapyOriginal source